Market Place
Sourcing Support
All News #Library
Biotech
REC-4881 TUPELO Trial Shows Rapid Polyp Reduction In FAP
08 Dec 2025 //
GLOBENEWSWIRE
Recursion Reports Q3 2025 Financials & Business Update
05 Nov 2025 //
GLOBENEWSWIRE
REC-4881 Shows Reduced Polyp Burden in FAP: Phase 1b/2 Data
04 May 2025 //
GLOBENEWSWIRE
Recursion Reports Interim Data for REC-617 in Phase 1 Trial
09 Dec 2024 //
GLOBENEWSWIRE
Recursion Doses First Patient in Phase 1/2 Study of REC-1245
03 Dec 2024 //
GLOBENEWSWIRE
Recursion Doses First Patient In Phase 2 Study Of REC-3964
22 Oct 2024 //
GLOBENEWSWIRE
Recursion Gets FDA Clearance for REC-1245 New Drug
02 Oct 2024 //
GLOBENEWSWIRE
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
18 Jul 2023 //
FOOL
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.